These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4026183)

  • 1. Systemic availability of oral slow-release morphine in man.
    Moore RA; McQuay HJ; Bullingham RE; Baldwin D; Allen MC
    Ann Clin Biochem; 1985 May; 22 ( Pt 3)():226-31. PubMed ID: 4026183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.
    Vater M; Smith G; Aherne GW; Aitkenhead AR
    Br J Anaesth; 1984 Aug; 56(8):821-7. PubMed ID: 6743446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.
    Hoskin PJ; Hanks GW; Aherne GW; Chapman D; Littleton P; Filshie J
    Br J Clin Pharmacol; 1989 Apr; 27(4):499-505. PubMed ID: 2719903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients.
    Poulain P; Hoskin PJ; Hanks GW; A-Omar O; Walker VA; Johnston A; Turner P; Aherne GW
    Br J Anaesth; 1988 Nov; 61(5):569-74. PubMed ID: 3207527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine sulphate slow release. Comparison with i.m. morphine for postoperative analgesia.
    Derbyshire DR; Bell A; Parry PA; Smith G
    Br J Anaesth; 1985 Sep; 57(9):858-65. PubMed ID: 4027102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled-release morphine tablets. A double-blind trial in dental surgery patients.
    Hanks GW; Rose NM; Aherne GW; Piall EM; Fairfield S; Trueman T
    Br J Anaesth; 1981 Dec; 53(12):1259-64. PubMed ID: 7032558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-pass effect of morphine in rats.
    Iwamoto K; Klaassen CD
    J Pharmacol Exp Ther; 1977 Jan; 200(1):236-44. PubMed ID: 833759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interindividual variation in the ratio between plasma morphine and its metabolites in cancer patients.
    Tateishi M; Ohashi K; Kobayashi K; Hashimoto T; Yamaguchi J; Fujioka H; Izawa K; Masada M
    Int J Clin Pharmacol Res; 2003; 23(2-3):75-82. PubMed ID: 15018021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.
    Wilkinson TJ; Robinson BA; Begg EJ; Duffull SB; Ravenscroft PJ; Schneider JJ
    Cancer Chemother Pharmacol; 1992; 31(3):251-4. PubMed ID: 1464164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food on the comparative pharmacokinetics of modified-release morphine tablet formulations: Oramorph SR and MST Continus.
    Drake J; Kirkpatrick CT; Aliyar CA; Crawford FE; Gibson P; Horth CE
    Br J Clin Pharmacol; 1996 May; 41(5):417-20. PubMed ID: 8735684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.
    Savarese JJ; Goldenheim PD; Thomas GB; Kaiko RF
    Clin Pharmacokinet; 1986; 11(6):505-10. PubMed ID: 3802690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.
    Säwe J; Kager L; Svensson Eng JO; Rane A
    Br J Clin Pharmacol; 1985 Apr; 19(4):495-501. PubMed ID: 3994897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
    KuKanich B; Lascelles BD; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled-release morphine (MST Contin) in advanced cancer. The European experience.
    Hanks GW
    Cancer; 1989 Jun; 63(11 Suppl):2378-82. PubMed ID: 2655869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of a new sustained-release formulation of morphine.
    Araico A; Saadeddin A; Torres-Molina F; Peris JE
    Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL capsules) with MST Continus tablets in cancer patients with severe pain.
    O'Brien T; Mortimer PG; McDonald CJ; Miller AJ
    Palliat Med; 1997 Nov; 11(6):475-82. PubMed ID: 9519171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of morphine in children with chronic pain--comparison of controlled release and regular morphine sulphate tablets.
    Nahata MC
    J Clin Pharm Ther; 1991 Jun; 16(3):193-5. PubMed ID: 1869598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacokinetic profiles of two oral controlled-release morphine formulations in healthy young adults.
    Hunt TL; Kaiko RF
    Clin Ther; 1991; 13(4):482-8. PubMed ID: 1934000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.